In Episode #11, we’re talking about another QuarterWatch report (May 2018) from the Institute for Safe Medication Practices, or ISMP.  The report touches on the topic of antidepressant effectiveness, a big public health issue related to the popular anti-diarrheal medication Imodium A-D, and the crazy confusion and dispensing errors related to four product inhalers currently on the market and being sold under the brand Ellipta.

Show note links:

To read the QuarterWatch May 2018 report, click here.

To learn more about the ISMP, click here.

“In the News” –> Amazon bought PillPack! Read about it here.

Got a news story, question, or insider tip on a medication issue threatening consumer health? Email us at